ARCHIVES

Harvard’s DePinho Becomes Finalist at MD Anderson

This article is from The Cancer Letter archive.

Vol. 37 No. 20 | May 20, 2011

Download PDF Visit The Full Archive

Related Articles

Surveillance Colonoscopy Cost-Effective For High-Risk

July 30, 2010

Rabson’s Group Hears Suggestions On Carcinogenesis

November 25, 1977

FDA Committee Okays Carboplatin For Second Line Ovarian Cancer

January 6, 1989

In Brief: Reagan Names Hammer to Third Term As Cancer Panel chairman; RPMI Opens Survivor Clinic

July 31, 1987

Obituary: Patricia Delaney, FDA Cancer Liaison.

June 6, 2008

No Cancer Letter for Two Weeks

August 13, 1993